Differences in the hepatic signal transcription pathway and cytokine expression between thermal injury and sepsis.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 14625478)

Published in Shock on December 01, 2003

Authors

Dagmar Klein1, Ralf Einspanier, Ulrich Bolder, Marc G Jeschke

Author Affiliations

1: Klinik und Poliklinik für Chirurgie, Klinikum der Universität Regensburg, Germany.

Articles by these authors

Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74

Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol (2008) 10.17

A genomic storm in critically injured humans. J Exp Med (2011) 6.67

Ninety-day oral toxicity studies on two genetically modified maize MON810 varieties in Wistar Han RCC rats (EU 7th Framework Programme project GRACE). Arch Toxicol (2014) 2.91

Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med (2010) 2.51

Cytokine expression profile over time in severely burned pediatric patients. Shock (2006) 2.33

The German hospital malnutrition study. Clin Nutr (2006) 1.93

Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab (2009) 1.71

Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med (2008) 1.67

Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med (2007) 1.62

The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg (2006) 1.60

Serum cytokine differences in severely burned children with and without sepsis. Shock (2007) 1.59

The leading causes of death after burn injury in a single pediatric burn center. Crit Care (2009) 1.59

Benchmarking outcomes in the critically injured burn patient. Ann Surg (2014) 1.58

Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med (2002) 1.58

Emerging infections in burns. Surg Infect (Larchmt) (2009) 1.57

Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit Care Med (2014) 1.52

Body composition changes with time in pediatric burn patients. J Trauma (2006) 1.49

A genomic score prognostic of outcome in trauma patients. Mol Med (2009) 1.48

miR-Q: a novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol Biol (2008) 1.42

The effect of hepatocyte growth factor on gut mucosal apoptosis and proliferation, and cellular mediators after severe trauma. Surgery (2005) 1.42

Retinol binding protein: marker for insulin resistance and inflammation postburn? JPEN J Parenter Enteral Nutr (2011) 1.41

Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology (2004) 1.39

Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet (2012) 1.36

Development of new reconstructive techniques: use of Integra in combination with fibrin glue and negative-pressure therapy for reconstruction of acute and chronic wounds. Plast Reconstr Surg (2004) 1.35

Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominissuis infection. PLoS One (2011) 1.35

Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock (2008) 1.34

A review of gene and stem cell therapy in cutaneous wound healing. Burns (2008) 1.34

Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg (2005) 1.34

Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci U S A (2010) 1.33

Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res (2008) 1.30

Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Ann Surg (2012) 1.30

Deciphering the porcine intestinal microRNA transcriptome. BMC Genomics (2010) 1.30

Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer (2007) 1.30

Upper airway mucus deposition in lung tissue of burn trauma victims. Shock (2008) 1.30

Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther (2007) 1.29

Cytokine expression profile over time in burned mice. Cytokine (2008) 1.28

Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample. J Proteome Res (2009) 1.24

Age-dependent differences in survival after severe burns: a unicentric review of 1,674 patients and 179 autopsies over 15 years. J Am Coll Surg (2006) 1.23

Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med (2002) 1.22

Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev (2010) 1.20

The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg (2009) 1.20

Severe burn-induced endoplasmic reticulum stress and hepatic damage in mice. Mol Med (2009) 1.16

Are serum cytokines early predictors for the outcome of burn patients with inhalation injuries who do not survive? Crit Care (2008) 1.15

Extent and magnitude of catecholamine surge in pediatric burned patients. Shock (2010) 1.15

Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stress. Shock (2010) 1.13

Occurrence of multiorgan dysfunction in pediatric burn patients: incidence and clinical outcome. Ann Surg (2014) 1.12

Treatment of second degree facial burns with allografts--preliminary results. Burns (2005) 1.09

Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg (2009) 1.09

IGF-1 protects intestinal epithelial cells from oxidative stress-induced apoptosis. J Surg Res (2006) 1.09

Pathophysiology of burns. Wien Med Wochenschr (2009) 1.08

M2b monocytes predominated in peripheral blood of severely burned patients. J Immunol (2010) 1.05

Effects of exercise training on resting energy expenditure and lean mass during pediatric burn rehabilitation. J Burn Care Res (2010) 1.05

Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg (2004) 1.05

Plasma proteome response to severe burn injury revealed by 18O-labeled "universal" reference-based quantitative proteomics. J Proteome Res (2010) 1.05

Human Wharton's jelly mesenchymal stem cells promote skin wound healing through paracrine signaling. Stem Cell Res Ther (2014) 1.05

Nutrition in burns: Galveston contributions. JPEN J Parenter Enteral Nutr (2011) 1.04

The role of hyperglycemia in burned patients: evidence-based studies. Shock (2010) 1.04

Changes in cardiac physiology after severe burn injury. J Burn Care Res (2011) 1.04

Propranolol decreases cardiac work in a dose-dependent manner in severely burned children. Surgery (2011) 1.03

Inhalation injury in severely burned children does not augment the systemic inflammatory response. Crit Care (2007) 1.03

Intestinal expression of TFF and related genes during postnatal development in a piglet probiotic trial. Cell Physiol Biochem (2009) 1.03

Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol (2005) 1.03

Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children. Ann Surg (2009) 1.02

Monozygotic twin model reveals novel embryo-induced transcriptome changes of bovine endometrium in the preattachment period. Biol Reprod (2005) 1.02

Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages. J Surg Res (2007) 1.02

Short-term weightlessness produced by parabolic flight maneuvers altered gene expression patterns in human endothelial cells. FASEB J (2011) 1.00

Intestinal Salmonella typhimurium infection leads to miR-29a induced caveolin 2 regulation. PLoS One (2013) 0.99

Metabolism modulators in sepsis: propranolol. Crit Care Med (2007) 0.99

Burn teams and burn centers: the importance of a comprehensive team approach to burn care. Clin Plast Surg (2009) 0.99

Insulin increases resistance to burn wound infection-associated sepsis. Crit Care Med (2010) 0.99

Degradation of Cry1Ab protein from genetically modified maize in the bovine gastrointestinal tract. J Agric Food Chem (2005) 0.97

Effects of incremental starvation on gut mucosa. Dig Dis Sci (2003) 0.97

The use of exenatide in severely burned pediatric patients. Crit Care (2010) 0.96

Amnion in the treatment of pediatric partial-thickness facial burns. Burns (2007) 0.96

The use of dermal substitutes in burn surgery: acute phase. Wound Repair Regen (2014) 0.95

A porcine model of full-thickness burn, excision and skin autografting. Burns (2008) 0.95

Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients. Ann Surg (2006) 0.95

Urinary cortisol and catecholamine excretion after burn injury in children. J Clin Endocrinol Metab (2008) 0.95

Differential gene regulation under altered gravity conditions in follicular thyroid cancer cells: relationship between the extracellular matrix and the cytoskeleton. Cell Physiol Biochem (2011) 0.95

Identification of factors contributing to hepatomegaly in severely burned children. Shock (2005) 0.94

Impact of anesthesia, analgesia, and euthanasia technique on the inflammatory cytokine profile in a rodent model of severe burn injury. Shock (2010) 0.94

Mortality related to gender, age, sepsis, and ethnicity in severely burned children. Shock (2005) 0.93

Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. J Proteome Res (2010) 0.93

Burn plus lipopolysaccharide augments endoplasmic reticulum stress and NLRP3 inflammasome activation and reduces PGC-1α in liver. Shock (2014) 0.93

The properties of an "ideal" burn wound dressing--what do we need in daily clinical practice? Results of a worldwide online survey among burn care specialists. Burns (2012) 0.92

Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? Curr Opin Clin Nutr Metab Care (2011) 0.92

Combined gene and stem cell therapy for cutaneous wound healing. Mol Pharm (2011) 0.90

α-Tocopherol adipose tissue stores are depleted after burn injury in pediatric patients. Am J Clin Nutr (2010) 0.90

Selected pro-inflammatory factor transcripts in bovine endometrial epithelial cells are regulated during the oestrous cycle and elevated in case of subclinical or clinical endometritis. Reprod Fertil Dev (2010) 0.90

Concatameric cloning of porcine microRNA molecules after assembly PCR. Biochem Biophys Res Commun (2008) 0.90

Proteomics improves the prediction of burns mortality: results from regression spline modeling. Clin Transl Sci (2012) 0.90

Prenatal testosterone excess alters Sertoli and germ cell number and testicular FSH receptor expression in rams. Am J Physiol Endocrinol Metab (2010) 0.90

Expression of hyaluronan synthases and corresponding hyaluronan receptors is differentially regulated during oocyte maturation in cattle. Biol Reprod (2003) 0.90

Benefit of Kupffer cell modulation with glycine versus Kupffer cell depletion after liver transplantation in the rat: effects on postischemic reperfusion injury, apoptotic cell death graft regeneration and survival. Transpl Int (2005) 0.89

Quantification and accurate normalisation of small RNAs through new custom RT-qPCR arrays demonstrates Salmonella-induced microRNAs in human monocytes. BMC Genomics (2012) 0.89

Long-term oxandrolone treatment increases muscle protein net deposition via improving amino acid utilization in pediatric patients 6 months after burn injury. Surgery (2011) 0.89

Clinical review: Glucose control in severely burned patients - current best practice. Crit Care (2013) 0.89